News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SQUINTO STEPHEN P
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/20/2022 |
4
| SQUINTO STEPHEN P (10% Owner) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 4,818 shares
@ $0
Granted 15,318 options to buy
@ $35.42, valued at
$542.6k
|
|
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| SQUINTO STEPHEN P (10% Owner) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 1,106 shares
@ $0
Granted 6,998 options to buy
@ $75.94, valued at
$531.4k
|
|
| 04/28/2021 |
4
| SQUINTO STEPHEN P (10% Owner) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Sold 201 shares
@ $75.0498, valued at
$15.1k
Sold 19,231 shares
@ $76.2018, valued at
$1.5M
|
|
| 04/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2021 |
4
| SQUINTO STEPHEN P (10% Owner) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Sold 511 shares
@ $75.0773, valued at
$38.4k
Sold 1,057 shares
@ $75.0147, valued at
$79.3k
|
|
| 08/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/22/2020 |
4
| SQUINTO STEPHEN P (10% Owner) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 7,464 options to buy
@ $38.03, valued at
$283.9k
|
|
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2019 |
4
| SQUINTO STEPHEN P (10% Owner) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Converted 6,078,103 shares
@ $0
Converted 1,053,204 shares
@ $0
Bought 275,000 shares
@ $18, valued at
$5M
Converted 6,078,103 convertible preferred
@ $0
Converted 1,053,204 convertible preferred
@ $0 |
|
| 09/16/2019 |
4
| SQUINTO STEPHEN P (10% Owner) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 29,983 options to buy
@ $18, valued at
$539.7k
Granted 40,000,000 convertible preferred
@ $0
Granted 6,931,142 convertible preferred
@ $0 |
|
| 10/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/25/2016 |
4
| SQUINTO STEPHEN P (Director) has filed a Form 4 on Audentes Therapeutics, Inc. |
| 10/28/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/07/2014 |
4
| SQUINTO STEPHEN P (EVP, Chief Global Ops. Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Sold 5,100 shares
@ $169.95, valued at
$866.7k
Sold 4,925 shares
@ $174.95, valued at
$861.6k
Exercised 10,025 options to buy
@ $42.66, valued at
$427.7k
|
|
| 09/26/2014 |
4
| SQUINTO STEPHEN P (EVP, Chief Global Ops. Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Sold 76 shares
@ $159.5, valued at
$12.1k
|
|
| 08/05/2014 |
4
| SQUINTO STEPHEN P (EVP, Chief Global Ops. Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Sold 1,662 shares
@ $157.42, valued at
$261.6k
|
|
| 03/04/2014 |
4
| SQUINTO STEPHEN P (EVP, Chief Global Ops. Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Granted 4,000 shares
@ $0
Granted 49,200 options to buy
@ $176.8, valued at
$8.7M
|
|
| 02/10/2014 |
4
| SQUINTO STEPHEN P (EVP, Chief Global Ops. Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Sold 3,800 shares
@ $155.11, valued at
$589.4k
Sold 3,800 shares
@ $155.11, valued at
$589.4k
Granted 9,745 shares
@ $0
Sold 1,600 shares
@ $155.55, valued at
$248.9k
Sold 20 shares
@ $157.51, valued at
$3.2k
Sold 1,635 shares
@ $167.31, valued at
$273.6k
Exercised 3,800 options to buy
@ $93.83, valued at
$356.6k
|
|
| 02/05/2014 |
4
| SQUINTO STEPHEN P (EVP, Chief Global Ops. Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Sold 852 shares
@ $157.14, valued at
$133.9k
Sold 3,200 shares
@ $153.63, valued at
$491.6k
Sold 3,300 shares
@ $157.1, valued at
$518.4k
Sold 29,637 shares
@ $155, valued at
$4.6M
Exercised 7,876 options to buy
@ $22.9, valued at
$180.4k
Exercised 6,250 options to buy
@ $42.66, valued at
$266.6k
Exercised 10,813 options to buy
@ $78.88, valued at
$852.9k
Exercised 3,800 options to buy
@ $93.83, valued at
$356.6k
|
|
| 01/31/2014 |
4
| SQUINTO STEPHEN P (EVP, Chief Global Ops. Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Sold 1,100 shares
@ $133.31, valued at
$146.6k
Sold 18 shares
@ $133.21, valued at
$2.4k
|
|
| 11/05/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/30/2013 |
4
| SQUINTO STEPHEN P (EVP, Chief Global Ops. Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Sold 39,537 shares
@ $124.06, valued at
$4.9M
Sold 500 shares
@ $124.76, valued at
$62.4k
Sold 1,000 shares
@ $123.89, valued at
$123.9k
Exercised 32,437 options to buy
@ $78.88, valued at
$2.6M
Exercised 7,600 options to buy
@ $93.83, valued at
$713.1k
|
|
| 08/07/2013 |
4
| SQUINTO STEPHEN P (EVP, Chief Global Ops. Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Sold 852 shares
@ $116.87, valued at
$99.6k
|
|
| 08/02/2013 |
4
| SQUINTO STEPHEN P (EVP, Chief Global Ops. Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Sold 4,912 shares
@ $115.05, valued at
$565.1k
Sold 2,963 shares
@ $116.04, valued at
$343.8k
Sold 4,858 shares
@ $114.95, valued at
$558.4k
Sold 1,392 shares
@ $116.12, valued at
$161.6k
Exercised 7,875 options to buy
@ $22.9, valued at
$180.3k
Exercised 6,250 options to buy
@ $42.66, valued at
$266.6k
|
|
| 08/01/2013 |
4
| SQUINTO STEPHEN P (EVP, Chief Global Ops. Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Sold 1,120 shares
@ $110.86, valued at
$124.2k
|
|
| 07/16/2013 |
4
| SQUINTO STEPHEN P (EVP, Chief Global Ops. Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Exercised 6,876 shares
@ $17.98, valued at
$123.6k
Exercised 11,124 shares
@ $22.9, valued at
$254.7k
Sold 18,000 shares
@ $119.9, valued at
$2.2M
Sold 6,876 options to buy
@ $17.98, valued at
$123.6k
Sold 11,124 options to buy
@ $22.9, valued at
$254.7k
|
|
| 05/01/2013 |
4
| SQUINTO STEPHEN P (EVP, Global Ops. Officer) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Sold 36,299 shares
@ $98.96, valued at
$3.6M
Sold 200 shares
@ $99.51, valued at
$19.9k
Exercised 16,499 options to buy
@ $22.9, valued at
$377.8k
Exercised 20,000 options to buy
@ $42.66, valued at
$853.2k
|
|
| 03/12/2013 |
4
| SQUINTO STEPHEN P (EVP, Head of R&D) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Sold 16,915 shares
@ $91.21, valued at
$1.5M
Sold 3,085 shares
@ $92.17, valued at
$284.3k
Exercised 13,750 options to buy
@ $17.98, valued at
$247.2k
Exercised 6,250 options to buy
@ $22.9, valued at
$143.1k
|
|
| 02/08/2013 |
4
| SQUINTO STEPHEN P (EVP, Head of R&D) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Granted 4,500 shares
@ $0
Granted 60,800 options to buy
@ $93.83, valued at
$5.7M
|
|
| 07/11/2012 |
4
| SQUINTO STEPHEN P (EVP, Research & Development) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Sold 44,100 shares
@ $100.34, valued at
$4.4M
Sold 4,700 shares
@ $100.98, valued at
$474.6k
Sold 1,200 shares
@ $101.81, valued at
$122.2k
Exercised 50,000 options to buy
@ $17.98, valued at
$899k
|
|
| 06/08/2012 |
4
| SQUINTO STEPHEN P (EVP, Research & Development) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Sold 50,000 shares
@ $90, valued at
$4.5M
Exercised 5,664 options to buy
@ $17.65, valued at
$100k
Exercised 44,336 options to buy
@ $17.65, valued at
$782.5k
|
|
| 02/22/2012 |
4
| SQUINTO STEPHEN P (EVP, Research & Development) has filed a Form 4 on ALEXION PHARMACEUTICALS INC|
Txns:
| Sold 48,481 shares
@ $81.266, valued at
$3.9M
Sold 6,779 shares
@ $82.03, valued at
$556.1k
Exercised 5,260 options to buy
@ $11.915, valued at
$62.7k
Exercised 50,000 options to buy
@ $17.6475, valued at
$882.4k
|
|
|
|
|